[ESPR] QoQ Quarter Result on 30-Sep-2003 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
29-Sep-2003
Financial Year
2003
Quarter
30-Sep-2003 [#Q3]
Profit Trend
QoQ- 22.19%
YoY- 5.97%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/09/12 30/06/12 31/03/12 30/09/03 30/06/03 31/03/03 31/12/02 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -3,351 -3,166 -2,449 -6,563 -8,435 -7,406 -6,619 -6.73%
Tax 362 304 261 578 922 633 692 -6.42%
NP -3,351 -3,166 -2,449 -6,563 -8,435 -7,406 -6,619 -6.73%
Tax Rate - - - - - - - -
Total Cost 3,351 3,166 2,449 6,563 8,435 7,406 6,619 -6.73%
Ratio Analysis
30/09/12 30/06/12 31/03/12 30/09/03 30/06/03 31/03/03 31/12/02 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/12 30/06/12 31/03/12 30/09/03 30/06/03 31/03/03 31/12/02 CAGR
EPS -0.35 -0.33 -0.25 -1.42 -2.00 -1.76 -1.58 -14.31%
EPS Diluted -0.35 -0.33 -0.25 -1.42 -2.00 -1.76 -1.58 -14.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.